News Updates

Company News

Industry Trends

National policy

In-depth Special Report on Innovative Pharmaceutical and Biologic Drugs (Part 1): ADCs—The Commercialization Wave of ADC Therapeutics Is Upon Us. We Focus on Three Core Investment Opportunities: Platform Value, New Breakthroughs in Treatment, and the Outsourcing Industry.

Release time:

2020-12-17

Source:

Author:

Recommended News

03-06

Image name

Improve detection methods for mental disorders and reduce the room for improper practices.

Improve detection methods for mental disorders and reduce the room for improper practices.

04-22

Image name

Another prescription drug application submitted by our company has been approved by the National Medical Products Administration for conversion to an over-the-counter drug.

Another prescription drug application submitted by our company has been approved by the National Medical Products Administration for conversion to an over-the-counter drug.

06-21

Image name

Breaking News: The application submitted by our agency to convert the prescription drug “Yinhuang Containing Oral Drops” into an over-the-counter (OTC) drug has been approved and publicly announced by the National Medical Products Administration.

Breaking News: The application submitted by our agency to convert the prescription drug “Yinhuang Containing Oral Drops” into an over-the-counter (OTC) drug has been approved and publicly announced by the National Medical Products Administration.

12-20

Image name

Good news about the signing

Good news about the signing

Rico International (Beijing) Medicine Technology Co., Ltd.

Tel: +86-10-53329998

Address: Room 905A, Building B, East Zone, Jianwai SOHO, No. 39, Middle Section of East Third Ring Road, Chaoyang District, Beijing

Facebook Linkedin Twitter Tumblr Pinterest

©2026 Rico International (Beijing) Medicine Technology Co., Ltd.  Powered by：CEglobal

Business license